The intense decrease in cardiovascular diseases (CVD) and cerebrovascular accident (stroke) in particular age groups were attributed to two particular reasons. These two significant supporters are the far reaching treatment of hypertension that is available around the world and, subsequently, its consequential enhancements. In spite of this particular advancement, there is a determined gap between the rates that are published by public health targets and the attained blood pressure (BP) control rates. There are several elements that could possibly be significant supporters of the difference between populace hypertension control targets and at present noticed levels of control. Between these gaps mentioned above lies the degree to which the hypertension patients comply with treatment that is recommended by their physicians. The primary objective of this logical assertion is to sum up the present status of information on the commitment of drug nonadherence to the public predominance of lowly control of blood pressure, techniques for estimating medicine adherence and their related difficulties. It also includes the hazard factors for antihypertensive prescription nonadherence, and methodologies for further developing adherence to antihypertensive meds at both the individual and wellbeing framework levels.